Pharmaron Beijing (HKG:3759, SHE:300759) reported a net profit attributable to owners of 308.4 million yuan for the quarter ended Sept. 30, a 12.62% drop from the previous year's quarter, according to a Tuesday filing with the Hong Kong bourse.
Earnings per share were 0.1744 yuan, a decline of 12.93% from a year earlier.
Revenue for the quarter increased 10.02% on-year to 3.21 billion yuan, according to the filing.
Price (HKD): $15.82, Change: $-0.60, Percent Change: -3.65%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。